Cut through the forums and the hype: understand what peptides are, how they work, what the research actually shows, and why many of them are unapproved research chemicals, not proven therapies.
The best way to learn about peptides is to start with the biology, what peptides are as signaling molecules, then look honestly at the evidence and regulatory status of the popular ones. Some peptide drugs like the GLP-1s are FDA-approved and well-studied; many others, including BPC-157 and TB-500, are not approved, rest largely on animal data, and are sold as research chemicals. LearnAI teaches the science and the evidence without hype. It is strictly educational, not medical advice, and gives no dosing or sourcing guidance, anything you'd act on belongs with a licensed clinician.
Peptides are one of the most hyped and least understood topics in health right now. Online they're presented as miracle molecules for healing, muscle, skin, and aging; in reality they're a broad class of signaling compounds where a few are rigorously proven drugs and many are unapproved substances riding on preliminary animal studies. Telling those apart is the whole game, and almost no one online does it honestly.
LearnAI teaches peptides as a science, not a shopping list. You'll learn what a peptide actually is, how these molecules signal in the body, and then work through the popular ones, GLP-1 agonists, BPC-157, TB-500, GHK-Cu and others, looking squarely at what the human evidence does and doesn't support, and where each one stands with regulators as of 2026.
This is important: this course is educational only. It is not medical advice, it will not tell you how to dose, source, or obtain anything, and it treats unapproved peptides as exactly that. Many popular peptides are not FDA-approved and are sold as research chemicals labeled 'not for human use.' Anything you might actually act on is a conversation for a licensed clinician.
5 weeks at your own pace, roughly 3-4 hours per week · built by LearnAI, adjusted to your level and goals
This is an example of the course plan LearnAI generates — yours will be personalized from your first message.
Start with the biology so the rest makes sense: peptides as short chains of amino acids that act as signals in the body.
Before any specific peptide, learn the lens: how to tell strong human evidence from promising animal data and anecdote.
Look at peptides that are genuinely FDA-approved and well-studied, so you have a benchmark for what real evidence looks like.
Examine the healing-and-recovery peptides honestly, the animal data, the sparse human evidence, and their unapproved status.
Survey the rest of the popular landscape, skin, growth-hormone-related, and 'longevity' peptides, with the same honest lens.
Pull it together into a durable framework for evaluating any peptide claim you encounter, and knowing when to stop and ask a doctor.
Peptides went mainstream fast, and the information hasn't caught up. GLP-1 drugs put peptide therapeutics on every front page, and that halo effect spilled onto a crowd of unapproved compounds being marketed with the same confidence and far less evidence. Understanding the science lets you see which claims are grounded and which are borrowing credibility they haven't earned.
2026 is a genuinely active moment for this. The FDA's Pharmacy Compounding Advisory Committee reviewed several peptides including BPC-157 and TB-500 for compounding eligibility in July 2026, and reclassification news generated a wave of confusion about what's 'legal' or 'approved', two very different things. Learning the fundamentals now means you can read that news accurately instead of through a marketer's spin.
The single most useful thing about peptides is knowing which are real, approved drugs and which are unapproved compounds on thin evidence. LearnAI holds that line clearly, using well-studied peptides as a benchmark so you can see how far the popular research chemicals fall short.
Most peptide hype rests on animal studies presented as if they apply to humans. LearnAI teaches you the difference between preclinical and clinical evidence, so when you see a bold claim you can immediately ask the right question: has this actually been shown in people?
It states plainly when a peptide is not FDA-approved, when it's a compounded substance, and when it's sold as a research chemical 'not for human use.' It also explains why 2026's reclassification news does not mean these compounds are proven or endorsed.
This course explains the science; it will never tell you how to dose, source, or obtain a peptide. Peptides are drugs, and unapproved ones carry real unknowns. For anything you would actually put in your body, LearnAI directs you to a licensed clinician instead of playing one.
Peptides are short chains of amino acids, the same building blocks that make up proteins, just far smaller. In the body they mostly act as signals, telling cells to do things like release a hormone or start a repair process. That signaling role is why they're interesting as potential drugs, but 'peptide' describes a huge, varied class, from proven medicines to unproven research compounds.
No. As of 2026, BPC-157 and TB-500 are not FDA-approved drugs. Much of the enthusiasm around them comes from animal studies, and completed human randomized trials are essentially absent for TB-500 and very limited for BPC-157. They have often been sold as research chemicals labeled 'not for human use.' The 2026 compounding advisory review concerns whether they can be legally compounded, which is not the same as being proven safe, effective, or approved.
No. This is strictly educational. LearnAI will teach you what peptides are, how they work, and what the evidence shows, but it gives no dosing, protocols, or sourcing instructions, and it won't tell you how to obtain anything. Peptides are drugs; unapproved ones carry real and sometimes unknown risks. Anything you'd actually act on is a conversation for a licensed clinician.
Yes, GLP-1 receptor agonists like semaglutide are peptide-based medicines, and they're a useful example of what a genuinely approved, well-studied peptide drug looks like, with large trials and regulatory oversight behind them. That's a sharp contrast with the unapproved research peptides. The GLP-1 course covers those medications in depth; still, any decision about them belongs with your doctor.
In 2026 there was significant news about the FDA reconsidering how certain peptides are handled in pharmacy compounding, which some marketing framed as 'legalization' or 'approval.' Those are different things. Changing compounding rules doesn't grant FDA approval, doesn't validate a specific use or dose, and doesn't establish a benefit-risk profile. Learning the distinction is exactly why understanding the regulatory basics matters.
Beyond the substance's own unknown long-term effects in humans, a major documented risk is product quality, contaminated, mislabeled, underdosed, or degraded material from unreliable sources. Because these compounds aren't regulated as approved medicines, what's in the vial may not match the label. This is one of many reasons a licensed clinician, not a course or a forum, is the right place for any real decision.
No. Everything here is educational, it's meant to help you understand the science and read claims critically, not to guide treatment. It doesn't diagnose, prescribe, or account for your health history and medications. For anything you'd consider doing, talk to a licensed clinician who can evaluate your specific situation.
Tell LearnAI your goal and your level. It builds your course and starts teaching in under a minute — free, no account needed.
Start Learning Free — No Account Needed